Details of the Drug

General Information of Drug (ID: DMO1U56)

Drug Name
KTE-C19
Indication
Disease Entry ICD 11 Status REF
Acute lymphoblastic leukaemia 2A85 Phase 1 [1]
Cross-matching ID
TTD ID
D0B3DV

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)